Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson’s disease pathogenesis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0533
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson’s disease pathogenesis ; day:17 ; month:9 ; year:2018 ; pages:1-18
Acta neuropathologica ; (17.9.2018), 1-18
- Creator
-
Hughes, Craig D.
- Contributor
-
Choi, Minee L.
Ryten, Mina
Hopkins, Lee
Drews, Anna
Botía, Juan A.
Iljina, Maria
Rodrigues, Magarida
Gagliano, Sarah A.
Gandhi, Sonia
Bryant, Clare
Klenerman, David
SpringerLink (Online service)
- DOI
-
10.1007/s00401-018-1907-y
- URN
-
urn:nbn:de:101:1-2018110314271157143873
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hughes, Craig D.
- Choi, Minee L.
- Ryten, Mina
- Hopkins, Lee
- Drews, Anna
- Botía, Juan A.
- Iljina, Maria
- Rodrigues, Magarida
- Gagliano, Sarah A.
- Gandhi, Sonia
- Bryant, Clare
- Klenerman, David
- SpringerLink (Online service)
Other Objects (12)
Salivary alpha-synuclein (total and oligomeric form): potential biomarkers in Parkinson’s disease
Transmission of alpha-synuclein in Parkinson’s disease
Mitochondrial dynamics in alpha-synuclein model of Parkinson`s disease
Transmission von Alpha-Synuclein beim Morbus Parkinson
Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson’s disease
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
The role of alpha-synuclein on transcriptional deregulation in Parkinson’s disease
Peptide-based approaches to directly target alpha-synuclein in Parkinson’s disease
Immune responses to oligomeric α-synuclein in Parkinson’s disease peripheral blood mononuclear cells
Detection of Dermal Alpha-Synuclein Deposits as a Biomarker for Parkinson’s Disease
Salivary alpha-synuclein (total and oligomeric form): potential biomarkers in Parkinson’s disease
Transmission of alpha-synuclein in Parkinson’s disease
Mitochondrial dynamics in alpha-synuclein model of Parkinson`s disease
Transmission von Alpha-Synuclein beim Morbus Parkinson
Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson’s disease
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
The role of alpha-synuclein on transcriptional deregulation in Parkinson’s disease
Peptide-based approaches to directly target alpha-synuclein in Parkinson’s disease
Immune responses to oligomeric α-synuclein in Parkinson’s disease peripheral blood mononuclear cells
Detection of Dermal Alpha-Synuclein Deposits as a Biomarker for Parkinson’s Disease
Salivary alpha-synuclein (total and oligomeric form): potential biomarkers in Parkinson’s disease
Transmission of alpha-synuclein in Parkinson’s disease
Mitochondrial dynamics in alpha-synuclein model of Parkinson`s disease
Transmission von Alpha-Synuclein beim Morbus Parkinson
Cell-to-cell transmitted alpha-synuclein recapitulates experimental Parkinson’s disease
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles
Parkinson’s Disease–Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance
The role of alpha-synuclein on transcriptional deregulation in Parkinson’s disease
Peptide-based approaches to directly target alpha-synuclein in Parkinson’s disease
Immune responses to oligomeric α-synuclein in Parkinson’s disease peripheral blood mononuclear cells